Patients with Ifit1low CRC benefited from high stromal Stat1 expression immediately after diagnosis, indicating that low expression of tumor cell-intrinsic Stat1-Ido1 sensitizes tumors to immune attack. The gene discussed is IDO1; the disease is neoplasm.